annual SGA:
$12.57B+$49.00M(+0.39%)Summary
- As of today (May 21, 2025), NVS annual SGA is $12.57 billion, with the most recent change of +$49.00 million (+0.39%) on December 31, 2024.
- During the last 3 years, NVS annual SGA has fallen by -$261.00 million (-2.03%).
- NVS annual SGA is now -30.38% below its all-time high of $18.05 billion, reached on December 31, 2011.
Performance
NVS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$3.06B-$443.00M(-12.65%)Summary
- As of today (May 21, 2025), NVS quarterly SGA is $3.06 billion, with the most recent change of -$443.00 million (-12.65%) on March 31, 2025.
- Over the past year, NVS quarterly SGA has increased by +$218.00 million (+7.68%).
- NVS quarterly SGA is now -36.33% below its all-time high of $4.80 billion, reached on December 31, 2011.
Performance
NVS quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$178.53B-$4.00B(-2.19%)Summary
- As of today (May 21, 2025), NVS TTM SGA is $178.53 billion, with the most recent change of -$4.00 billion (-2.19%) on March 31, 2025.
- Over the past year, NVS TTM SGA has increased by +$166.06 billion (+1332.12%).
- NVS TTM SGA is now -17.97% below its all-time high of $217.64 billion.
Performance
NVS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NVS Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.4% | +7.7% | +1332.1% |
| 3 y3 years | -2.0% | -12.9% | +1293.7% |
| 5 y5 years | -12.6% | -12.3% | +1129.1% |
NVS Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.0% | +3.1% | -14.6% | +7.7% | -18.0% | +181.0% |
| 5 y | 5-year | -12.6% | +3.1% | -22.1% | +58.8% | -18.0% | +212.3% |
| alltime | all time | -30.4% | +81.0% | -36.3% | +102.7% | -18.0% | +648.2% |
NVS Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $3.06B(-12.7%) | $12.78B(+1.7%) |
| Dec 2024 | $12.57B(+0.4%) | $3.50B(+11.7%) | $12.57B(+0.5%) |
| Sep 2024 | - | $3.13B(+1.4%) | $12.51B(+0.3%) |
| Jun 2024 | - | $3.09B(+8.8%) | $12.47B(0.0%) |
| Mar 2024 | - | $2.84B(-17.5%) | $12.47B(-0.4%) |
| Dec 2023 | $12.52B(+2.7%) | $3.44B(+11.4%) | $12.52B(+2.1%) |
| Sep 2023 | - | $3.09B(0.0%) | $12.26B(+1.3%) |
| Jun 2023 | - | $3.09B(+6.9%) | $12.10B(-3.9%) |
| Mar 2023 | - | $2.89B(-9.2%) | $12.59B(-4.7%) |
| Dec 2022 | $12.19B(-4.9%) | $3.18B(+8.4%) | $13.21B(+10.5%) |
| Sep 2022 | - | $2.94B(-18.0%) | $11.96B(-5.4%) |
| Jun 2022 | - | $3.58B(+2.0%) | $12.64B(-1.4%) |
| Mar 2022 | - | $3.51B(+82.3%) | $12.81B(-0.1%) |
| Dec 2021 | $12.83B(-9.6%) | $1.93B(-46.8%) | $12.83B(-13.5%) |
| Sep 2021 | - | $3.62B(-3.6%) | $14.82B(+1.4%) |
| Jun 2021 | - | $3.75B(+6.4%) | $14.63B(+2.7%) |
| Mar 2021 | - | $3.53B(-10.1%) | $14.24B(+0.3%) |
| Dec 2020 | $14.20B(-1.2%) | $3.92B(+14.8%) | $14.20B(+0.1%) |
| Sep 2020 | - | $3.42B(+1.5%) | $14.18B(-0.9%) |
| Jun 2020 | - | $3.37B(-3.4%) | $14.31B(-1.5%) |
| Mar 2020 | - | $3.49B(-10.7%) | $14.53B(+1.1%) |
| Dec 2019 | $14.37B(+4.8%) | $3.90B(+10.0%) | $14.37B(+1.6%) |
| Sep 2019 | - | $3.55B(-1.0%) | $14.14B(+2.1%) |
| Jun 2019 | - | $3.58B(+7.7%) | $13.85B(+0.7%) |
| Mar 2019 | - | $3.33B(-9.4%) | $13.76B(+0.3%) |
| Dec 2018 | $13.72B(+10.0%) | $3.68B(+12.8%) | $13.72B(+18.8%) |
| Sep 2018 | - | $3.26B(-6.7%) | $11.55B(-3.5%) |
| Jun 2018 | - | $3.50B(+6.4%) | $11.97B(-2.5%) |
| Mar 2018 | - | $3.28B(+117.6%) | $12.28B(-1.5%) |
| Dec 2017 | $12.46B(-12.2%) | $1.51B(-59.0%) | $12.46B(-15.7%) |
| Sep 2017 | - | $3.68B(-3.4%) | $14.79B(+1.9%) |
| Jun 2017 | - | $3.81B(+9.6%) | $14.52B(+1.1%) |
| Mar 2017 | - | $3.47B(-9.5%) | $14.36B(+1.2%) |
| Dec 2016 | $14.19B(-0.4%) | $3.84B(+12.9%) | $14.19B(-0.3%) |
| Sep 2016 | - | $3.40B(-6.8%) | $14.24B(-0.4%) |
| Jun 2016 | - | $3.65B(+10.4%) | $14.30B(+0.2%) |
| Mar 2016 | - | $3.31B(-14.9%) | $14.27B(+0.2%) |
| Dec 2015 | $14.25B(-5.0%) | $3.88B(+12.2%) | $14.25B(-0.6%) |
| Sep 2015 | - | $3.46B(-4.3%) | $14.33B(-0.7%) |
| Jun 2015 | - | $3.62B(+10.2%) | $14.43B(-1.4%) |
| Mar 2015 | - | $3.28B(-17.2%) | $14.64B(-2.4%) |
| Dec 2014 | $14.99B(-1.6%) | $3.96B(+11.2%) | $14.99B(-1.2%) |
| Sep 2014 | - | $3.56B(-6.8%) | $15.17B(-0.7%) |
| Jun 2014 | - | $3.83B(+5.2%) | $15.28B(+0.3%) |
| Mar 2014 | - | $3.64B(-12.3%) | $15.24B(-3.7%) |
| Dec 2013 | $15.24B(+0.8%) | $4.15B(+12.8%) | $15.82B(+11.9%) |
| Sep 2013 | - | $3.67B(-2.9%) | $14.14B(-2.8%) |
| Jun 2013 | - | $3.78B(-10.3%) | $14.55B(-3.7%) |
| Mar 2013 | - | $4.22B(+71.0%) | $15.12B(+0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $15.12B(-16.2%) | $2.47B(-39.6%) | $15.12B(-13.4%) |
| Sep 2012 | - | $4.09B(-6.1%) | $17.45B(-1.7%) |
| Jun 2012 | - | $4.35B(+3.2%) | $17.75B(-1.6%) |
| Mar 2012 | - | $4.21B(-12.3%) | $18.05B(-0.0%) |
| Dec 2011 | $18.05B(+14.3%) | $4.80B(+9.5%) | $18.05B(+0.1%) |
| Sep 2011 | - | $4.39B(-5.5%) | $18.03B(+3.7%) |
| Jun 2011 | - | $4.64B(+10.1%) | $17.39B(+5.8%) |
| Mar 2011 | - | $4.22B(-11.8%) | $16.43B(+4.0%) |
| Dec 2010 | $15.80B(+10.2%) | $4.78B(+27.9%) | $15.80B(+4.1%) |
| Sep 2010 | - | $3.74B(+1.4%) | $15.18B(+2.3%) |
| Jun 2010 | - | $3.69B(+2.9%) | $14.85B(+1.1%) |
| Mar 2010 | - | $3.58B(-14.0%) | $14.69B(+2.5%) |
| Dec 2009 | $14.33B(+1.7%) | $4.17B(+22.4%) | $14.33B(+3.5%) |
| Sep 2009 | - | $3.40B(-3.6%) | $13.85B(-0.1%) |
| Jun 2009 | - | $3.53B(+9.5%) | $13.86B(-1.0%) |
| Mar 2009 | - | $3.23B(-12.4%) | $13.99B(-0.8%) |
| Dec 2008 | $14.10B(+6.3%) | $3.68B(+7.8%) | $14.10B(+0.0%) |
| Sep 2008 | - | $3.42B(-6.8%) | $14.09B(+1.7%) |
| Jun 2008 | - | $3.67B(+9.9%) | $13.86B(+2.5%) |
| Mar 2008 | - | $3.33B(-9.4%) | $13.52B(+2.0%) |
| Dec 2007 | $13.26B(+10.7%) | $3.68B(+15.7%) | $13.26B(+1.4%) |
| Sep 2007 | - | $3.18B(-4.4%) | $13.08B(+2.0%) |
| Jun 2007 | - | $3.33B(+8.4%) | $12.82B(+2.9%) |
| Mar 2007 | - | $3.07B(-12.2%) | $12.46B(+3.1%) |
| Dec 2006 | $11.97B(+12.6%) | $3.50B(+19.6%) | $12.08B(+11.8%) |
| Sep 2006 | - | $2.92B(-1.4%) | $10.81B(+1.0%) |
| Jun 2006 | - | $2.96B(+9.9%) | $10.71B(+0.9%) |
| Mar 2006 | - | $2.70B(+21.2%) | $10.61B(-0.2%) |
| Dec 2005 | $10.63B(+6.4%) | $2.23B(-21.1%) | $10.63B(-2.8%) |
| Sep 2005 | - | $2.82B(-1.6%) | $10.94B(+3.3%) |
| Jun 2005 | - | $2.87B(+5.4%) | $10.58B(+2.8%) |
| Mar 2005 | - | $2.72B(+7.6%) | $10.29B(+0.6%) |
| Dec 2004 | $9.99B(+8.2%) | $2.53B(+2.3%) | $10.24B(+1.9%) |
| Sep 2004 | - | $2.47B(-4.1%) | $10.04B(+1.1%) |
| Jun 2004 | - | $2.58B(-3.2%) | $9.94B(+2.1%) |
| Mar 2004 | - | $2.66B(+14.1%) | $9.73B(+5.4%) |
| Dec 2003 | $9.23B(+17.2%) | $2.33B(-1.2%) | $9.23B(+4.1%) |
| Sep 2003 | - | $2.36B(-0.5%) | $8.87B(+5.1%) |
| Jun 2003 | - | $2.37B(+9.7%) | $8.44B(+2.8%) |
| Mar 2003 | - | $2.16B(+9.9%) | $8.21B(+35.8%) |
| Dec 2002 | $7.88B(+10.0%) | $1.97B(+2.0%) | $6.04B(+48.3%) |
| Sep 2002 | - | $1.93B(-9.9%) | $4.07B(+90.1%) |
| Jun 2002 | - | $2.14B(+24.6%) | $2.14B(+24.6%) |
| Dec 2001 | $7.17B(-11.2%) | - | - |
| Jun 2001 | - | $1.72B(+4.4%) | $1.72B(+4.4%) |
| Dec 2000 | $8.07B(+16.3%) | - | - |
| Jun 2000 | - | $1.65B | $1.65B |
| Dec 1999 | $6.94B(-11.8%) | - | - |
| Dec 1998 | $7.87B | - | - |
FAQ
- What is Novartis AG annual SGA?
- What is the all time high annual SGA for Novartis AG?
- What is Novartis AG annual SGA year-on-year change?
- What is Novartis AG quarterly SGA?
- What is the all time high quarterly SGA for Novartis AG?
- What is Novartis AG quarterly SGA year-on-year change?
- What is Novartis AG TTM SGA?
- What is the all time high TTM SGA for Novartis AG?
- What is Novartis AG TTM SGA year-on-year change?
What is Novartis AG annual SGA?
The current annual SGA of NVS is $12.57B
What is the all time high annual SGA for Novartis AG?
Novartis AG all-time high annual SGA is $18.05B
What is Novartis AG annual SGA year-on-year change?
Over the past year, NVS annual SGA has changed by +$49.00M (+0.39%)
What is Novartis AG quarterly SGA?
The current quarterly SGA of NVS is $3.06B
What is the all time high quarterly SGA for Novartis AG?
Novartis AG all-time high quarterly SGA is $4.80B
What is Novartis AG quarterly SGA year-on-year change?
Over the past year, NVS quarterly SGA has changed by +$218.00M (+7.68%)
What is Novartis AG TTM SGA?
The current TTM SGA of NVS is $178.53B
What is the all time high TTM SGA for Novartis AG?
Novartis AG all-time high TTM SGA is $217.64B
What is Novartis AG TTM SGA year-on-year change?
Over the past year, NVS TTM SGA has changed by +$166.06B (+1332.12%)